Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer

Journal: Nature Communications

Published: 2018-01-02

DOI: 10.1038/s41467-017-02283-9

Affiliations: 8

Authors: 16

Go to article
Institutions FC
Department of Physiology and Pharmacology, TAU, Israel 0.58
Institute for Drug Research (IDR), HUJI, Israel 0.13
The Acute Care Hospital, Chaim Sheba Medical Center, Israel 0.09
Department of Cell and Developmental Biology, TAU, Israel 0.06
Center for Bioinformatics and Computational Biology (CBCB), UMCP, United States of America (USA) 0.05
Department of Computer Science, UMCP, United States of America (USA) 0.05
Department of Pathology, TAU, Israel 0.03
The Blavatnik School of Computer Science (CS), TAU, Israel 0.02

Return